Table:
begin	end	state
1	25	cytoplasmic
26	44	transmembrane
45	63	non-cytoplasmic
64	83	transmembrane
84	93	cytoplasmic
94	114	transmembrane
115	119	non-cytoplasmic
120	138	transmembrane
139	158	cytoplasmic
159	182	transmembrane
183	187	non-cytoplasmic
188	207	transmembrane
208	253	cytoplasmic
254	273	transmembrane
274	292	non-cytoplasmic
293	311	transmembrane
312	322	cytoplasmic
323	341	transmembrane
342	351	non-cytoplasmic
352	373	transmembrane
374	381	cytoplasmic
382	404	transmembrane
405	414	non-cytoplasmic
415	435	transmembrane
436	449	cytoplasmic

Input:
>PfGW456L13_887 FitnessBrowser__pseudo13_GW456_L13:PfGW456L13_887
MFAFFRPAAHQAPLPEEKIDSTYRRLRWQIFAGIFIGYAGYYLLRKNFSLAMPYLIDEGY
SRGQLGLAMSAIAIAYGLSKFLMGLVSDRSNPRFFLPFGLLVSAGVMFIFGFAPWATSSV
TMMFILLFINGWAQGMGWPPSGRTMVHWWSQKERGGVVSVWNVAHNVGGGLIGPLFLIGM
GLFNDWHAAFYVPAAVALAVAVFAFVTMRDTPQSVGLPPIEQYKNDYPEGYDASHEEEFS
AKEIFVKYVLRNKMLWYIALANVFVYLLRYGVLDWAPTYLKEAKGFTVDKTSWAYFFYEW
AGIPGTLLCGWMSDKIFRGNRGLTGMVFMALVTVATLVYWLNPAGNPMVDMIALLSIGFL
IYGPVMLIGLQALELAPKKAAGTAAGFTGLFGYLGGSVAASAAMGYTVDHFGWDGGFVLL
VGACLLAMAFLAPTLRHKQIASQGREALA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server